VNDA insider buying and SEC filings, explained
Vanda Pharmaceuticals Inc. · CIK 1347178
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$2.8M
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Mar 2, 2026 | Sale | Kevin Patrick Moran (CFO) sold 42,442 shares at about $8.27 ($351K). Holdings down 9% to 411,380 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 4, 2026 |
| Mar 2, 2026 | Sale | Joakim Wijkstrom (SVP, Chief Marketing Officer) sold 30,800 shares at about $8.27 ($255K). Holdings down 8% to 333,469 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 4, 2026 |
| Mar 2, 2026 | Sale | Timothy Williams (SVP & General Counsel) sold 42,434 shares at about $8.27 ($351K). Holdings down 10% to 377,450 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 4, 2026 |
| Mar 2, 2026 | Sale | Gunther Birznieks (SVP, Business Development) sold 42,431 shares at about $8.27 ($351K). Holdings down 8% to 494,197 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 4, 2026 |
| Mar 2, 2026 | Sale | Mihael Hristos Polymeropoulos (CEO and Director) sold 156,235 shares at about $8.17 ($1.3M). Holdings down 5% to 2,704,496 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 4, 2026 |
| Feb 23, 2026 | Sale | Tage Honore (Director) sold 30,000 shares at $8.03 ($241K). Holdings down 24% to 93,469 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 24, 2026 |
14 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow VNDA in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.